Triomics is a tech-enabled clinical trial partner helping companies run faster, transparent and high-quality clinical trials in India and SEA. Triomics is funded by Y Combinator, Nexus Venture Partners and General Catalyst.
https://www.ycombinator.com/companies/triomics
https://www.ycombinator.com/companies/triomics
Location: India, Delhi, New Delhi
Employees: 51-200
Investors 2
| Date | Name | Website |
| 26.03.2023 | Lightspeed... | lsvp.com |
| 26.04.2021 | Y Combinat... | ycombinato... |
Mentions in press and media 4
| Date | Title | Description |
| 23.03.2021 | Y Combinator’s new batch features its largest group of Indian startups | Y Combinator’s latest batch — W21 — features 350 startups from 41 nations. Fifty percent of the firms, the highest percentage to date, in the new batch are based outside of the United States. India is the second-largest demographic represen... |
| - | Triomics | “Triomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny.” |
| - | Triomics | “Triomics | We advance oncology research and care operations by helping accelerate trial enrollment, quality improvement projects, streamline healthcare operations, and more.” |
| - | Triomics | “Triomics is at the forefront of clinical research technology, utilizing advanced interoperability frameworks, machine learning, and robust data standards to enable the use of clinical data for research. Our primary offerings include a tech... |